Target intelligence / Profile preview

Bacterial DNA polymerase III (Pol III) (Pol III)

Target
Pol III
Molecular classification
Enzyme, DNA polymerase, C-family DNA polymerase, Transferase
01

Overview

Bacterial DNA polymerase III (Pol III) is the primary enzyme complex responsible for the replication of the bacterial chromosome [7, 13]. It is a multi-subunit holoenzyme that exhibits high processivity and fidelity, essential for rapid and accurate genome duplication during cell division [11, 17]. The enzyme consists of a catalytic core (alpha, epsilon, and theta subunits), a sliding clamp (beta subunit) for processivity, and a clamp loader complex [7, 8]. In many bacteria, Pol III exists in two main forms: PolC, predominant in low-GC Gram-positive bacteria, and DnaE, found in Gram-negative bacteria and Mycobacteria [4, 15]. Because Pol III is structurally distinct from eukaryotic DNA polymerases, belonging to the C-family rather than the B-family, it serves as an attractive target for the development of narrow-spectrum and broad-spectrum antibiotics [14, 19]. Inhibitors such as ibezapolstat target the PolC subunit by mimicking natural nucleotides and sequestering the enzyme into inactive complexes, effectively halting bacterial growth [18, 21]. This target is particularly relevant for treating infections like Clostridioides difficile and multidrug-resistant tuberculosis [22, 26]. Recent clinical developments have focused on narrow-spectrum inhibitors that minimize damage to the host microbiome [18, 22].

Other names
DNA polymerase III holoenzymePol III HEReplicative DNA polymeraseC-family DNA polymeraseDNA-directed DNA polymerase IIIPolCDnaE
02

Mechanism of action

Inhibition of DNA synthesis by competing with natural nucleotides (e.g., dGTP) or sequestering the enzyme into inactive ternary complexes with DNA; some inhibitors also disrupt the interaction between the polymerase and the sliding clamp (beta-clamp/DnaN).

03

Biological functions

DNA replicationChromosomal DNA synthesisProofreadingLeading strand synthesisLagging strand synthesis
04

Disease associations

InfectionBacterial infectionClostridioides difficile infectionTuberculosisMultidrug-resistant bacterial infection
05

Safety considerations

Development of antibiotic resistancePotential cross-reactivity with host polymerasesSelectivity between Gram-positive and Gram-negative species
06

Interacting drugs

Ibezapolstat

7 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial DNA replication ratePresence of polC or dnaE genes

Beyond the preview

Go deeper on Bacterial DNA polymerase III (Pol III) (Pol III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA polymerase III (Pol III) (Pol III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call